Skip to main content
Top
Published in: Endocrine 2/2022

01-05-2022 | Gestational Diabetes | Letter to the Editor

ROC-curves—fundamentals for proper use

Authors: Johanne Holm Toft, Inger Økland, Ingvild Dalen

Published in: Endocrine | Issue 2/2022

Login to get access

Excerpt

We read with interest the article by Chume and co-workers entitled ‘Is there a role for glycated albumin in the diagnosis of gestational diabetes mellitus?’, recently published in Endocrine [1]. The aim of the study was to assess the clinical utility of glycated albumin (GA) in the diagnosis of gestational diabetes. The authors present Receiver Operating Characteristics (ROC) curves of GA, glycated hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) using the Oral Glucose Tolerance Test (OGTT) as the diagnostic test (gold standard). The area under the curve (AUC) values reported are 0.531, 0.743, and 0.865 for GA, HbA1c and FPG, respectively. The authors conclude that GA does not have the ability to correctly discriminate those with and without gestational diabetes. Hence, they disapprove the use of GA as a standalone diagnostic test of GDM. We agree with Chume and co-workers in that conclusion. In our ROC analysis of GA and HbA1c in the diagnostics of gestational diabetes in Norwegian women, we found similar results with AUC values of 0.531 (GA) and 0.623 (HbA1c) [2]. …
Metadata
Title
ROC-curves—fundamentals for proper use
Authors
Johanne Holm Toft
Inger Økland
Ingvild Dalen
Publication date
01-05-2022
Publisher
Springer US
Published in
Endocrine / Issue 2/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03035-6

Other articles of this Issue 2/2022

Endocrine 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.